Development Program Management Sample Clauses

Development Program Management. The contractor shall establish and maintain a BATMAV System IMP to support cost, schedule and performance aspects of the effort required by the development effort of this contract. The IMP shall include systems engineering and software processes, certifications, tasks, reviews and events. The contractor shall provide planning, organizing, controlling, staffing and direction functions to meet these requirements. The contractor shall establish and maintain a CWBS for the efforts of the program. The contractor shall provide agendas and minutes for Contractor-Government meetings/conferences and audits IAW DI-ADMIN-81250A (CDRL A004). Use or disclosure of information contained on this page is subject to the restrictions stated on the title page of this document. The contractor shall maintain an IMS in contractor format that reflects the efforts identified in this SOW. The schedule shall include development, integration milestones, and reviews. The contractor shall provide updates to the IMS on a monthly basis IAW DI-MISC-81183A/T (CDRL A008). The contractor shall perform contract, finance and IPT activities as described by the scope of production management sections 3.3.1.1.2, 3.3.1.1.3 and 3.3.1.1.4 for the development phase of this contract.
Sample 1
AutoNDA by SimpleDocs
Development Program Management. The individuals set forth on Exhibit D as Program Managers are the technical contacts for each party for this Agreement and, unless otherwise named in the applicable Project Statement, for any Project Statement and any ongoing coordination during the term of each Project Statement. The Program Managers will be responsible for day-to-day communications between the parties regarding the technical aspects of each Project Statement. Either party may change its Program Manager at any time and from time to time by giving the other party written notice. Each Program Manager will be responsible for (i) monitoring the schedules and progress of work for each Project Statement; (ii) receiving and submitting requests for information and/or assistance; (iii) determining whether a request he or she receives for information and/or assistance from the other Program Manager is necessary for Licensor to complete the work specified in any Project Statement; (iv) receiving and submitting deliverables; (v) cooperating with the other Program Manager to coordinate acceptance testing in accordance with Section 2.8; and (vi) supervising and recording the exchange of confidential information pursuant to this Agreement. The Program Managers will meet remotely every 60 days, or for any alternative interval as set forth in a Project Statement, during the term of the Project Statement to discuss the progress of the development effort and, if applicable, to exchange information and deliverables.
Sample 1
Development Program Management. (a) The Development Program shall be managed by the Drug Development Committee which shall administer and be responsible for (i) oversight of the research and development program to be carried out and (ii) setting and approving budgets, releasing funds, approving charges to the Near Term Development Plan or the Development Plan and in general approving all tasks and the timetable for completion of such task in the development of one or more Compounds for use in the Field. (b) The Drug Development Committee shall include a designee of LICENSEE, Xxxxxxxxx Xxxxxxx X. Dwek of Oxford University, and until such time as MONSANTO shall have declined all of its Rights of First Refusal as set forth in Article 4 hereof, or having exercised such rights failed to negotiate a definitive license agreement with LICENSEE, a designee of MONSANTO. Xxxxxxxxx Xxxx shall serve as Chairman of the Committee. All decisions taken by the Drug Development Committee shall be by consensus; provided, however, that until such time as MONSANTO shall have exercised its Rights of First Refusal pursuant to Article 4.1 hereof and entered into either the Development and License Agreement or the Marketing Agreement, as therein specified, MONSANTO shall have an advisory role but no vote on decisions relating to setting and approving budgets or releasing funds. (c) The Drug Development Committee shall meet at least quarterly to review and revise, if necessary, the Drug Development Program. Written minutes of all decisions taken by the Drug Development Committee shall be signed by all members of the Drug Development Committee. The Drug Development Committee shall provide MONSANTO with detailed quarterly reports describing progress of the development of the Compound(s) for use in the Field including any information with respect to side effects or contraindications noted.
Sample 1
Development Program Management 
Sample 1

Related to Development Program Management

  • Program Management 1.1.01 Implement and operate an Immunization Program as a Responsible Entity 1.1.02 Identify at least one individual to act as the program contact in the following areas: 1. Immunization Program Manager;

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Project Management Plan 3.2.1 Developer is responsible for all quality assurance and quality control activities necessary to manage the Work, including the Utility Adjustment Work. Developer shall undertake all aspects of quality assurance and quality control for the Project and Work in accordance with the approved Project Management Plan, Good Industry Practice and applicable Law. 3.2.2 Developer shall develop the Project Management Plan and its component parts, plans and other documentation in accordance with the requirements set forth in Section 1.5.2.5

  • Professional Development Program (a) The parties agree to continue a Professional Development Program for the maintenance and development of the faculty members' professional competence and effectiveness. It is agreed that maintenance of currency of subject knowledge, the improvement of performance of faculty duties, and the maintenance and improvement of professional competence, including instructional skills, are the primary professional development activities of faculty members. (b) Information collected as part of this program shall be the sole property of the faculty member. This information or any judgments arising from this program shall not be used to determine non-renewal or termination of a faculty member's contract, suspension or dismissal of a faculty member, denial of advancement on the salary scale, nor affect any other administrative decisions pertaining to the promotion or employment status of the faculty member. (c) A joint advisory committee consisting of three regular faculty members who shall be elected by and are P.D. Committee Chairpersons and three administrators shall make recommendations for the operation, financing and management of the Professional Development Program.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Program Development NWESD agrees that priority in the development of new applications services by XXXXX shall be in accordance with the expressed direction of the XXXXX Board of Directors operating under their bylaws.

  • Program Manager Owner may designate a Program Manager to administer the Project and this Contract. In lieu of a Program Manager, Design Professional may be designated to perform the role of Program Manager. The Program Manager may also be designated as the Owner’s Representative, and if no Owner’s Representative is designated, the Program Manager shall be the Owner’s Representative.

  • Development Services During the term of this Agreement, the Provider agrees to provide to or on behalf of the Port the professional services and related items described in Exhibit A (collectively, the “Development Services”) in accordance with the terms and conditions of this Agreement. The Provider specifically agrees to include at least one Port representative in any economic development negotiations or discussions in which the Provider is involved concerning (i) a port-related business prospect or (ii) a business transaction which will ultimately require Port involvement, financial or otherwise.

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!